Taiwanese Journal of Obstetrics and Gynecology
Volume 48, Issue 1 , Pages 3-8 , March 2009

Placental Abnormalities and Preeclampsia in Trisomy 13 Pregnancies

  • Chih-Ping Chen

      Affiliations

    • Department of Obstetrics and Gynecology, Mackay Memorial Hospital, Taipei, Taiwan
    • Department of Medical Research, Mackay Memorial Hospital, Taipei, Taiwan
    • Department of Biotechnology, Asia University, Taipei, Taiwan
    • School of Chinese Medicine, College of Chinese Medicine, China Medical University, Taichung, Taipei, Taiwan
    • Institute of Clinical and Community Health Nursing, National Yang-Ming University, Taipei, Taiwan
    • Corresponding Author InformationCorrespondence to: Dr Chih-Ping Chen, Department of Obstetrics and Gynecology, Mackay Memorial Hospital, 92, Section 2, Chung-Shan North Road, Taipei, Taiwan

,Accepted 12 January 2009.

References 

  1. Arizawa M , Nakayama M . Pathological analysis of the placenta in trisomies 21, 18 and 13 . Nippon Sanka Fujinka Gakkai Zasshi . 1992;44:9–13 [In Japanese]
  2. Labbé S , Copin H , Choiset A , Girard S , Barbet JP . The placenta and trisomies 13, 18, 21 . J Gynecol Obstet Biol Reprod (Paris) . 1989;18:989–996 [In French]
  3. Metzenbauer M , Hafner E , Schuchter K , Philipp K . First-trimester placental volume as a marker for chromosomal anomalies: preliminary results from an unselected population . Ultrasound Obstet Gynecol . 2002;19:240–242
  4. Wegrzyn P , Faro C , Falcon O , Peralta CF , Nicolaides KH . Placental volume measured by three-dimensional ultrasound at 11 to 13 +6 weeks of gestation: relation to chromosomal defects . Ultrasound Obstet Gynecol . 2005;26:28–32
  5. Feinberg RF , Kliman HJ , Cohen AW . Preeclampsia, trisomy 13, and the placental bed . Obstet Gynecol . 1991;78:505–508
  6. Jauniaux E , Hustin J . Chromosomally abnormal early ongoing pregnancies: correlation of ultrasound and placental histo-logical findings . Hum Pathol . 1998;29:1195–1199
  7. Rizzo G , Capponi A , Cavicchioni O , Vendola M , Arduini D . Placental vascularization measured by three-dimensional power Doppler ultrasound at 11 to 13 + 6 weeks' gestation in normal and aneuploid fetuses . Ultrasound Obstet Gynecol . 2007;30:259–262
  8. Jauniaux E , Halder A , Partington C . A case of partial mole associated with trisomy 13 . Ultrasound Obstet Gynecol . 1998;11:62–64
  9. Curtin WM , Marcotte MP , Myers LL , Brost BC . Trisomy 13 appearing as a mimic of a triploid partial mole . J Ultrasound Med . 2001;20:1137–1139
  10. Has R , Ibrahimoğlu L , Ergene H , Ermis H , Başaran S . Partial molar appearance of the placenta in trisomy 13 . Fetal Diagn Ther . 2002;17:205–208
  11. Moscoso G , Jauniaux E , Hustin J . Placental vascular anomaly with diffuse mesenchymal stem villous hyperplasia: a new clinico-pathological entity? . Pathol Res Pract . 1991;187:324–328
  12. Jauniaux E , Nicolaides KH , Hustin J . Perinatal features associated with placental mesenchymal dysplasia . Placenta . 1997;18:701–706
  13. Cohen MC , Roper EC , Sebire NJ , Stanek J , Anumba DOC . Placental mesenchymal dysplasia associated with fetal an-euploidy . Prenat Diagn . 2005;25:187–192
  14. Sander CM . Angiomatous malformation of placental chori-onic stem vessels and pseudo-partial molar placentas: report of five cases . Pediatr Pathol . 1993;13:621–633
  15. Chen CP , Chern SR , Wang TY , Huang ZD , Huang MC , Chuang CY . Pregnancy with concomitant chorangioma and placental vascular malformation with mesenchymal hyper-plasia . Hum Reprod . 1997;12:2553–2556
  16. Arizawa M , Nakayama M . Suspected involvement of the X chromosome in placental mesenchymal dysplasia . Congenit Anom (Kyoto) . 2002;42:309–317
  17. Müngen E , Dundar O , Muhcu M , Haholu A , Tunca Y . Pla-cental mesenchymal dysplasia associated with trisomy 13: sonographic findings . J Clin Ultrasound . 2008;36:454–456
  18. Bower C , Stanley F , Walters BN . Pre-eclampsia and trisomy 13 . Lancet . 1987;2:1032
  19. Evers J , Seelen J , Blankenborg G . Severe toxemia, hydramnios and trisomy 13-15 . Ned Tijdschr Verloskd Gynaecol . 1967;67:395–397
  20. Boyd PA , Lindenbaum RH , Redman C . Pre-eclampsia and trisomy 13: a possible association . Lancet . 1987;2:425–427
  21. Thornton JG , O'Donovan P , Stigter R , Williams J , Sullivan LG . Pre-eclampsia and trisomy 13 . Lancet . 1987;2:794
  22. Tuohy JF , James DK . Pre-eclampsia and trisomy 13 . Br J Obstet Gynaecol . 1992;99:891–894
  23. Heydanus R , Defoort P , Dhont M . Pre-eclampsia and trisomy 13 . Eur J Obstet Gynecol Reprod Biol . 1995;60:201–202
  24. Pedersen BW , Grønlund A . Severe pre-eclampsia and fetal trisomy 13 in a multiparous woman . Ugeskr Laeger . 2003;165:2108–2109 [In Danish]
  25. Bdolah Y , Palomaki GE , Yaron Y , et al.   Circulating angiogenic proteins in trisomy 13 . Am J Obstet Gynecol . 2006;194:239–245
  26. Kendall RL , Wang G , Thomas KA . Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR . Biochem Biophys Res Commun . 1996;226:324–328
  27. Shibuya M . Structure and function of VEGF/VEGF-receptor system involved in angiogenesis . Cell Struct Funct . 2001;26:25–35
  28. Kita N , Mitsushita J . A possible placental factor for preeclamp-sia: sFlt-1 . Curr Med Chem . 2008;15:711–715
  29. Maynard SE , Min JY , Merchan J , et al.   Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia . J Clin Invest . 2003;111:649–658
  30. Zhou Y , McMaster M , Woo K , et al.   Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclamp-sia and hemolysis, elevated liver enzymes, and low platelets syndrome . Am J Pathol . 2002;160:1405–1423
  31. Vuorela P , Helske S , Hornig C , Alitalo K , Weich H , Halmesmäki E . Amniotic fluid-soluble vascular endothelial growth factor receptor-1 in preeclampsia . Obstet Gynecol . 2000;95:353–357
  32. Koga K , Osuga Y , Yoshino O , et al.   Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia . J Clin Endocrinol Metab . 2003;88:2348–2351
  33. Sugimoto H , Hamano Y , Charytan D , et al.   Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria . J Biol Chem . 2003;278:12605–12608
  34. Tsatsaris V , Goffin F , Munaut C , et al.   Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences . J Clin Endocrinol Metab . 2003;88:5555–5563
  35. Bdolah Y , Sukhatme VP , Karumanchi SA . Angiogenic imbalance in the pathophysiology of preeclampsia: newer insights . Semin Nephrol . 2004;24:548–556
  36. Chaiworapongsa T , Romero R , Espinoza J , et al.   Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclamp-sia: Young Investigator Award . Am J Obstet Gynecol . 2004;190:1541–1550
  37. Hertig A , Berkane N , Lefevre G , et al.   Maternal serum sFlt1 concentration is an early and reliable predictive marker of preeclampsia . Clin Chem . 2004;50:1702–1703
  38. Karumanchi SA , Bdolah Y . Hypoxia and sFlt-1 in preeclamp-sia: the “chicken-and-egg” question . Endocrinology . 2004;145:4835–4837
  39. Levine RJ , Maynard SE , Qian C , et al.   Circulating angiogenic factors and the risk of preeclampsia . N Engl J Med . 2004;350:672–683
  40. Levine RJ , Thadhani R , Qian C , et al.   Urinary placental growth factor and risk of preeclampsia . JAMA . 2005;293:77–85
  41. Thadhani R , Mutter WP , Wolf M , et al.   First trimester pla-cental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia . J Clin Endocrinol Metab . 2004;89:770–775
  42. Venkatesha S , Toporsian M , Lam C , et al.   Soluble endoglin contributes to the pathogenesis of preeclampsia . Nat Med . 2006;12:642–649
  43. Wikström AK , Larsson A , Eriksson UJ , Nash P , Nordén-Lindeberg S , Olovsson M . Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late-onset preeclampsia . Obstet Gynecol . 2007;109:1368–1374
  44. Moore Simas TA , Crawford SL , Solitro MJ , Frost SC , Meyer BA , Maynard SE . Angiogenic factors for the prediction of preeclampsia in high-risk women . Am J Obstet Gynecol . 2007;197:244.e1–244.e8
  45. Baumann MU , Bersinger NA , Mohaupt MG , Raio L , Gerber S , Surbek DV . First-trimester serum levels of soluble endoglin and soluble fms-like tyrosine kinase-1 as first-trimester markers for late-onset preeclampsia . Am J Obstet Gynecol . 2008;199:266e1; 266e6
  46. Sela S , Itin A , Natanson-Yaron S , et al.   A novel human-specific soluble vascular endothelial growth factor receptor 1: cell-type-specific splicing and implications to vascular endothelial growth factor homeostasis and preeclampsia . Circ Res . 2008;102:1566–1574
  47. Lunell NO , Lewander R , Mamoun I , Nylund L , Sarby S , Thornstrom S . Uteroplacental blood flow in pregnancy induced hypertension . Scand J Clin Lab Invest . 1984;169(Suppl):28–35
  48. Genbacev O , Zhou Y , Ludlow JW , Fisher SJ . Regulation of human placental development by oxygen tension . Science . 1997;277:1669–1672
  49. Podjarny E , Baylis C , Losonczy G . Animal models of preeclampsia . Semin Perinatol . 1999;23:2–13
  50. Caniggia I , Mostachfi H , Winter J , et al.   Hypoxia-inducible factor-1 mediates the biological effects of oxygen on human trophoblast differentiation through TGFß(3) . J Clin Invest . 2000;105:577–587
  51. Rajakumar A , Whitelock KA , Weissfeld LA , Daftary AR , Markovic N , Conrad KP . Selective overexpression of the hypoxia-inducible transcription factor, HIF-2, in placentas from women with preeclampsia . Biol Reprod . 2001;64:499–506
  52. Fisher SJ . The placental problem: linking abnormal cytotro-phoblast differentiation to the maternal symptoms of preeclampsia . Reprod Biol Endocrinol . 2004;2:53
  53. Nagamatsu T , Fujii T , Kusumi M , et al.   Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia . Endocrinology . 2004;145:4838–4845
  54. Stepan H , Faber R . Elevated sFlt1 level and preeclampsia with parvovirus-induced hydrops . N Engl J Med . 2006;354:1857–1858
  55. Griffin CA , Emanuel BS , Hansen JR , Cavenee WK , Myers JC . Human collagen genes encoding basement membrane a1(IV) and a2(IV) chains map to the distal long arm of chromosome 13 . Proc Natl Acad Sci USA . 1987;84:512–516
  56. Killen PD , Francomano CA , Yamada Y , Modi WS , O'Brien SJ . Partial structure of the human a2(IV) collagen chain and chromosomal localization of the gene (COL4A2) . Hum Genet . 1987;77:318–324
  57. Bjørn SF , Hastrup N , Lund LR , Danø K , Larsen JF , Pyke C . Co-ordinated expression of MMP-2 and its putative activator, MT1-MMP, in human placentation . Mol Hum Reprod . 1997;3:713–723
  58. Pang ZJ , Xing FQ . Expression profile of trophoblast invasion-associated genes in the pre-eclamptic placenta . Br J Biomed Sci . 2003;60:97–101
  59. Johnson MP , Fitzpatrick E , Dyer TD , et al.   Identification of two novel quantitative trait loci for pre-eclampsia susceptibility on chromosomes 5q and 13q using a variance components-based linkage approach . Mol Hum Reprod . 2007;13:61–67
  60. Zintzaras E , Kitsios G , Harrison GA , et al.   Heterogeneity-based genome search meta-analysis for preeclampsia . Hum Genet . 2006;120:360–370
  61. Parimi N , Tromp G , Kuivaniemi H , et al.   Analytical approaches to detect maternal/fetal genotype incompatibilities that increase risk of pre-eclampsia . BMC Med Genet . 2008;9:60
  62. Galewska Z , Bańkowski E , Romanowicz L , Gogiel T , Wolańska M , Jaworski S . Preeclampsia-associated reduction of cathep-sin D activity in the umbilical cord . Clin Chim Acta . 2005;351:177–184
  63. Takeshita S , Kikuno R , Tezuka K , Amann E . Osteoblast-specific factor 2: cloning of a putative bone adhesion protein with homology with the insect protein fasciclin I . Biochem J . 1993;294:271–278
  64. Sasaki H , Roberts J , Lykins D , Fujii Y , Auclair D , Chen LB . Novel chemiluminescence assay for serum periostin levels in women with preeclampsia and in normotensive pregnant women . Am J Obstet Gynecol . 2002;186:103–108

PII: S1028-4559(09)60028-0

doi: 10.1016/S1028-4559(09)60028-0

Taiwanese Journal of Obstetrics and Gynecology
Volume 48, Issue 1 , Pages 3-8 , March 2009

Article Tools